As payer FWA controls tighten, false positives — legitimate care blocked or denied by blunt rules — become a significant cost in their own right. This instrument quantifies the cost of your current false-positive burden and assesses whether your control posture is optimised for the actual risk trade-off.
Each dimension targets a specific failure mode that causes decisions of this type to go wrong. The instrument is designed to surface the gaps that are most likely to be consequential — not to measure maturity against an idealised standard.
This instrument is in development for standalone release. It can be applied immediately as part of a Full Diagnostic or Strategic Bundle engagement. Contact us to discuss your specific decision context.